Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Polychronis Pavlidis

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 17, 2014
Diagnostic and clinical significance of Crohn's disease-specific anti-MZGP2 pancreatic antibodies by a novel ELISAPolychronis Pavlidis, Zakera Shums, Andreas L Koutsoumpas, et al.
Gastrointestinal Endoscopy|July 6, 2021
Near-focus narrow-band imaging classification of villous atrophy in suspected celiac disease: development and international validationShraddha Gulati, Andrew Emmanuel, Mark Ong, et al.
International Journal of Molecular Sciences|December 17, 2024
Non-<i>Helicobacter pylori Helicobacters</i>, a Treatable Provocateur of Parkinson's Disease: Hypothesis, Evidence and Species SpecificityWenjing Wang, Melvyn Smith, Richard Ellis, et al.
Clinical & Developmental Immunology|November 3, 2012
Ileal inflammation may trigger the development of GP2-specific pancreatic autoantibodies in patients with Crohn's diseasePolychronis Pavlidis, Ourania Romanidou, Dirk Roggenbuck, et al.
Frontline Gastroenterology|October 17, 2022
Faecal calprotectin is a surrogate marker of biliary inflammation in primary sclerosing cholangitis associated inflammatory bowel diseasePolychronis Pavlidis, Deepak Joshi, Yasser El Sherif, et al.
Journal for Immunotherapy of Cancer|September 16, 2022
Oral beclomethasone dipropionate is an effective treatment for immune checkpoint inhibitor induced colitisJames L Alexander, Hajir Ibraheim, Camellia Richards, et al.
Cellular and Molecular Gastroenterology and Hepatology|June 6, 2022
Cyclin-dependent Kinase 9 as a Potential Target for Anti-TNF-resistant Inflammatory Bowel DiseaseOmer S Omer, Arnulf Hertweck, Luke B Roberts, et al.
Frontline Gastroenterology|July 27, 2018
Golimumab: early experience and medium-term outcomes from two UK tertiary IBD centresMark A Samaan, Polychronis Pavlidis, Jonathan Digby-Bell, et al.
The Lancet. Gastroenterology & Hepatology|June 20, 2020
British Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitisNick Powell, Hajir Ibraheim, Tim Raine, et al.
The Biochemical Journal|June 5, 2025
Interplay of constipation, intestinal barrier dysfunction and fungal exposome in aetiopathogenesis of Parkinson's disease: hypothesis with supportive dataChianna Umamahesan, Aleksandra Pilcicka, Jennifer Yick, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 17, 2014
Diagnostic and clinical significance of Crohn's disease-specific anti-MZGP2 pancreatic antibodies by a novel ELISAPolychronis Pavlidis, Zakera Shums, Andreas L Koutsoumpas, et al.
Gastrointestinal Endoscopy|July 6, 2021
Near-focus narrow-band imaging classification of villous atrophy in suspected celiac disease: development and international validationShraddha Gulati, Andrew Emmanuel, Mark Ong, et al.
International Journal of Molecular Sciences|December 17, 2024
Non-<i>Helicobacter pylori Helicobacters</i>, a Treatable Provocateur of Parkinson's Disease: Hypothesis, Evidence and Species SpecificityWenjing Wang, Melvyn Smith, Richard Ellis, et al.
Clinical & Developmental Immunology|November 3, 2012
Ileal inflammation may trigger the development of GP2-specific pancreatic autoantibodies in patients with Crohn's diseasePolychronis Pavlidis, Ourania Romanidou, Dirk Roggenbuck, et al.
Frontline Gastroenterology|October 17, 2022
Faecal calprotectin is a surrogate marker of biliary inflammation in primary sclerosing cholangitis associated inflammatory bowel diseasePolychronis Pavlidis, Deepak Joshi, Yasser El Sherif, et al.
Journal for Immunotherapy of Cancer|September 16, 2022
Oral beclomethasone dipropionate is an effective treatment for immune checkpoint inhibitor induced colitisJames L Alexander, Hajir Ibraheim, Camellia Richards, et al.
Cellular and Molecular Gastroenterology and Hepatology|June 6, 2022
Cyclin-dependent Kinase 9 as a Potential Target for Anti-TNF-resistant Inflammatory Bowel DiseaseOmer S Omer, Arnulf Hertweck, Luke B Roberts, et al.
Frontline Gastroenterology|July 27, 2018
Golimumab: early experience and medium-term outcomes from two UK tertiary IBD centresMark A Samaan, Polychronis Pavlidis, Jonathan Digby-Bell, et al.
The Lancet. Gastroenterology & Hepatology|June 20, 2020
British Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitisNick Powell, Hajir Ibraheim, Tim Raine, et al.
The Biochemical Journal|June 5, 2025
Interplay of constipation, intestinal barrier dysfunction and fungal exposome in aetiopathogenesis of Parkinson's disease: hypothesis with supportive dataChianna Umamahesan, Aleksandra Pilcicka, Jennifer Yick, et al.
Pageof 5